neuroscience

In the Lab Claudia López Lloreda

STAT Plus: Researchers use machine learning to translate brain signals from a paralyzed patient into text

Exclusive Olivia Goldhill

STAT Plus: Athira Pharma CEO placed on leave amid allegations of altered images in her research papers

First Opinion Dana P. Goldman and Darius Lakdawalla

STAT Plus: FDA’s approval of aducanumab paves the way for ‘more momentous’ Alzheimer’s breakthroughs

Health Sara Reardon

Covid-19 gave scientists an opening to better understand how brain disorders arise

Biotech Adam Feuerstein

STAT Plus: STAT+ Conversations: A conversation on the latest in neuroscience and CNS drug development

First Opinion Anna Wexler

STAT Plus: A skeptic’s take on Neuralink and other consumer neurotech

In the Lab Usha Lee McFarling

STAT Plus: New monkey model of Alzheimer’s disease may accelerate search for human treatments

In the Lab Usha Lee McFarling

STAT Plus: ‘It looks like a spaghetti bowl’: Scientists reveal a precise structure in a fabled worm’s tangled brain

Biotech Matthew Herper

STAT Plus: Experts encouraged by Denali’s early results in study of Hunter syndrome drug

In the Lab Eric Boodman

STAT Plus: Genetic reprogramming rejuvenates nerve cells and restores vision in mice

Health Meghana Keshavan

A MacArthur ‘genius’ will likely use his grant to support his wife’s work — in the name of science

Health Tech Rebecca Robbins and Erin Brodwin

STAT Plus: Elon Musk’s Neuralink unveils prototype of brain implants — and looks toward clinical trials

The Readout LOUD Damian Garde and Adam Feuerstein

The FDA’s chaotic week, Trump’s effect on science, and Musk’s big reveal

Rebecca Robbins, Casey Ross and Erin Brodwin

STAT Health Tech: Elon Musk’s secretive brain implants startup & Verily’s move into health insurance

Special Report Erin Brodwin and Rebecca Robbins

STAT Plus: As Elon Musk’s Neuralink prepares to draw back the curtain, ex-employees describe rushed timelines clashing with science’s slow pace

Health Hyacinth Empinado and Theresa Gaffney

Watch: What day is it? How pandemic stress alters your perception of time

Biotech Damian Garde and Matthew Herper

STAT Plus: Coles-led Cerevel Therapeutics to raise $445 million to develop brain drugs with fewer side effects

In the Lab Theresa Gaffney

STAT Plus: How does exercise benefit the aging brain? Transfusing blood from active mice into sedentary ones suggests an answer

Biotech Adam Feuerstein

STAT Plus: Yumanity Therapeutics, Merck strike deal aimed at developing new medicines for neurodegenerative disease

In the Lab Juliet Isselbacher

By tricking mice into sensing fake smells, scientists decode how the brain recognizes scent

In the Lab Shraddha Chakradhar

STAT Plus: Researchers develop a non-invasive way to manipulate neurons to study behavior

In the Lab Megan Thielking

Scientists turn organs transparent — and use a new technique to capture 3D pictures of what’s inside

In the Lab Eric Boodman

The vodka trial: In search of a treatment for vocal disorders, a researcher puts patient anecdotes to the test

In the Lab Sharon Begley

Brain-imaging study shows ‘hot spot’ that may explain why African Americans feel greater pain

In the Lab Sharon Begley

A ‘landmark’ achievement: Scientists trace full wiring diagram of the fly brain’s core

First Opinion Donna Jackson Nakazawa

Microglia: a new target in the brain for depression, Alzheimer’s, and more?

In the Lab Sharon Begley

Scientists show mice an Orson Welles movie, then disprove dogma about how vision works

In the Lab Sharon Begley

Research using brains-in-a-dish forces a radical rethinking of Huntington’s disease

Health Andrew Joseph

A new Alzheimer’s therapy is approved in China, delivering a surprise for the field but also questions